Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure [4]

Journal of the American College of Cardiology

Volumn 46, Issue 1, 2005, Pages 182-

  Willenheimer, Ronnie ^a   Van Veldhuisen, Dirk J ^b   Ponikowski, Piotr ^b   Lechat, Philippe ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LETTER; MORBIDITY; MORTALITY; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BISOPROLOL; CARBAZOLES; DRUG ADMINISTRATION SCHEDULE; HEART FAILURE, CONGESTIVE; HUMANS; PROPANOLAMINES;

EID: 21344471228     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.04.011     Document Type: Letter

References (3)

1. K. Sliwa, G.R. Norton, N. Kone Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure J Am Coll Cardiol 44 2004 1825 1830
2. C.V. Leier Dismantling mandates in the treatment of heart failure J Am Coll Cardiol 44 2004 1831 1833
3. R. Willenheimer, E. Erdmann, F. Follath CIBIS-III investigators Comparison of treatment initiation with bisoprolol versus enalapril in chronic heart failure patients rationale and design of CIBIS-III Eur J Heart Fail 6 2004 493 500